Magellan Update April 2024

AGM AND TOUR OF FACILITY The Magellan Stem Cells Annual General Meeting of was held in December at the Braeside premises where Magellan Chair, Lou Panaccio conducted a fruitful meeting for those in attendance and those online. Several investors joined us after the meeting for a tour of the impressive new facility which was well […]

Magellan is pleased to announce the results of our Phase 1/2 allogeneic (donor) stem cell trial. The findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI)

Australia’s Federal Health Minister announces $7 million grant to Magellan Stem Cells

NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research

For more information please email info@magellanstemcells.com.au or call 03 9270 8080

Investment Enquiry

Download the full Investor Presentation